These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7297021)

  • 21. Pharmacokinetics of high-dose meperidine in surgical patients.
    Koska AJ; Kramer WG; Romagnoli A; Keats AS; Sabawala PB
    Anesth Analg; 1981 Jan; 60(1):8-11. PubMed ID: 7192957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro.
    Barbhaiya RH; Gerber AU; Craig WA; Welling PG
    Antimicrob Agents Chemother; 1982 Mar; 21(3):472-80. PubMed ID: 7103450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meperidine disposition in mother, neonate, and nonpregnant females.
    Kuhnert BR; Kuhnert PM; Prochaska AL; Sokol RJ
    Clin Pharmacol Ther; 1980 Apr; 27(4):486-91. PubMed ID: 7357807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary excretion of meperidine and normeperidine in man upon acute and chronic exposure to high altitude.
    Ritschel WA; Paulos C; Arancibia A; Pezzani M; Agrawal M; Wetzelsberger K; Lücker PW
    Methods Find Exp Clin Pharmacol; 1996; 18(1):49-53. PubMed ID: 8721256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of urinary pH on pethidine kinetics in healthy volunteer subjects. 2. A study of ten Chinese subjects.
    Chan K; Tse J; Jennings F; Orme ML
    Methods Find Exp Clin Pharmacol; 1987 Jan; 9(1):49-54. PubMed ID: 3573868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of pethidine under acidic urinary pH in man, 2. A pharmacokinetic analysis.
    Chan K
    Methods Find Exp Clin Pharmacol; 1982; 4(8):591-9. PubMed ID: 7169848
    [No Abstract]   [Full Text] [Related]  

  • 27. Kinetics of meperidine N-demethylation in the perfused rat liver preparation.
    Babiak LM; Cherry WF; Fayz S; Pang KS
    Drug Metab Dispos; 1984; 12(6):698-704. PubMed ID: 6150818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of cirrhosis on the disposition and elimination of meperidine in man.
    Klotz U; McHorse TS; Wilkinson GR; Schenker S
    Clin Pharmacol Ther; 1974 Oct; 16(4):667-75. PubMed ID: 4419525
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetic properties of intramuscular versus oral syrup paracetamol in Plasmodium falciparum malaria.
    Wattanakul T; Teerapong P; Plewes K; Newton PN; Chierakul W; Silamut K; Chotivanich K; Ruengweerayut R; White NJ; Dondorp AM; Tarning J
    Malar J; 2016 Apr; 15():244. PubMed ID: 27118212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot study on disposition and pain relief after i.m. administration of meperidine during the day or night.
    Ritschel WA; Bykadi G; Ford DJ; Bloomfield SS; Levy RC
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):218-23. PubMed ID: 6683251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioimmunoassay for normeperidine: studies on the N-dealkylation of meperidine and anileridine.
    Freeman DS; Gjika HB; Van Vunakis H
    J Pharmacol Exp Ther; 1977 Oct; 203(1):203-12. PubMed ID: 578528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration.
    Lees P; Ayliffe T; Maitho TE; Taylor JB
    Res Vet Sci; 1988 Jan; 44(1):57-67. PubMed ID: 3375589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and local responses to submucosal meperidine compared with other routes of administration.
    Schmitt M; Nazif MM; McKee KC; Zullo T; Venkataramanan R; Burckart G; Habucky K
    Pediatr Dent; 1994; 16(3):190-2. PubMed ID: 8058542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic-pharmacodynamic modelling of meperidine in goats (II): Modelling.
    Qiao GL; Fung KF
    J Vet Pharmacol Ther; 1994 Apr; 17(2):127-34. PubMed ID: 8040932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clearance of meperidine and its metabolite normeperidine in hemodialysis patients with chronic noncancer pain.
    Hsu CH; Lin TC; Lu CC; Lin SH; Ho ST
    J Pain Symptom Manage; 2014 Apr; 47(4):801-5. PubMed ID: 23870842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of meperidine (pethidine) in rabbit oral fluid: correlation with plasma concentrations after controlled administration.
    Cao J; Du Y; Wang YJ; Wu B; Jia J; Wei ZW; Yun KM; Liang W; Wang YY; Sun JH
    Pharmazie; 2018 Jun; 73(6):324-328. PubMed ID: 29880084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of fenoximone, a new cardiotonic, in healthy subjects.
    Alken RG; Belz GG; Haegele KD; Meinicke T; Schechter PJ
    Clin Pharmacol Ther; 1984 Aug; 36(2):209-16. PubMed ID: 6235081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meperidine pharmacokinetics following intravenous, peroral and buccal administration in beagle dogs.
    Ritschel WA; Neub M; Denson DD
    Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):811-5. PubMed ID: 3441166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absolute bioavailability of oral and intramuscular diazepam: effects of age and sex.
    Divoll M; Greenblatt DJ; Ochs HR; Shader RI
    Anesth Analg; 1983 Jan; 62(1):1-8. PubMed ID: 6849499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.